Palo Alto Investors LP Long-Term Concentrated

Location: Palo Alto, CA

CIK: 0001306923 · Show all filings

Period: Q1 2016 (← Previous) (Next →)

Filing Date: May 16, 2016

Total Value: $1.288B (100.0% shares, 0.0% debt)

Holdings (44)

— ABIOMED INC 17.1%
Value $221M Shares 2,325,959 Share Price $94.81 Est. Cost/Share $29.48 Unrealized @ Report Date —
UTHR UNITED THERAPEUTICS CORP DEL 13.2%
Value $170M Shares 1,525,654 Share Price $111.43 * Est. Cost/Share $81.75 Unrealized @ Report Date +54.8%
— ANACOR PHARMACEUTICALS INC 9.2%
Value $119M Shares 2,219,042 Share Price $53.45 Est. Cost/Share $24.12 Unrealized @ Report Date —
BMRN BIOMARIN PHARMACEUTICAL INC 8.6%
Value $111M Shares 1,340,347 Share Price $82.48 Est. Cost/Share $73.11 Unrealized @ Report Date +11.3%
— AMAG PHARMACEUTICALS INC 5.3%
Value $68M Shares 2,906,194 Share Price $23.40 Est. Cost/Share $30.80 Unrealized @ Report Date —
— CLOVIS ONCOLOGY INC 5.2%
Value $66.46M Shares 3,461,365 Share Price $19.20 Est. Cost/Share $57.85 Unrealized @ Report Date —
INSM INSMED INC 4.7%
Value $60.7M Shares 4,790,800 Share Price $12.67 * Est. Cost/Share $14.79 Unrealized @ Report Date -11.1%
— WRIGHT MED GROUP N V 2.8%
Value $36.37M Shares 2,190,957 Share Price $16.60 Est. Cost/Share $23.98 Unrealized @ Report Date —
VNDA VANDA PHARMACEUTICALS INC 2.6%
Value $33.7M Shares 4,030,908 Share Price $8.36 Est. Cost/Share $8.48 Unrealized @ Report Date -3.2%
— EPIZYME INC 2.5%
Value $32.18M Shares 2,655,479 Share Price $12.12 Est. Cost/Share $13.76 Unrealized @ Report Date —
FOLD AMICUS THERAPEUTICS INC 2.3%
Value $30.01M Shares 3,551,173 Share Price $8.45 * Est. Cost/Share $5.71 Unrealized @ Report Date +24.0%
PRTA PROTHENA CORP PLC 2.2%
Value $28.63M Shares 695,518 Share Price $41.16 * Est. Cost/Share $22.18 Unrealized @ Report Date +76.4%
GILD GILEAD SCIENCES INC 2.2%
Value $27.82M Shares 302,900 Share Price $91.86 * Est. Cost/Share $63.23 Unrealized @ Report Date +0.4%
— KARYOPHARM THERAPEUTICS INC 2.1%
Value $27.64M Shares 3,098,145 Share Price $8.92 Est. Cost/Share $20.94 Unrealized @ Report Date —
— CELGENE CORP 2.1%
Value $27.1M Shares 270,800 Share Price $100.09 Est. Cost/Share $97.13 Unrealized @ Report Date —
— MEDIVATION INC 1.9%
Value $24.16M Shares 525,462 Share Price $45.98 Est. Cost/Share $57.74 Unrealized @ Report Date —
— ENDO INTL PLC 1.8%
Value $23.33M Shares 828,630 Share Price $28.15 Est. Cost/Share $87.66 Unrealized @ Report Date —
— CEMPRA INC 1.7%
Value $21.3M Shares 1,215,833 Share Price $17.52 Est. Cost/Share $30.68 Unrealized @ Report Date —
STAA STAAR SURGICAL CO 1.5%
Value $19.52M Shares 2,641,875 Share Price $7.39 * Est. Cost/Share $8.11 Unrealized @ Report Date -16.5%
— SHIRE PLC 1.4%
Value $18.24M Shares 106,100 Share Price $171.90 Est. Cost/Share $227.14 Unrealized @ Report Date —
— ZELTIQ AESTHETICS INC 1.2%
Value $15.58M Shares 573,636 Share Price $27.16 Est. Cost/Share $26.16 Unrealized @ Report Date —
— ARIAD PHARMACEUTICALS INC 1.1%
Value $14.37M Shares 2,248,317 Share Price $6.39 Est. Cost/Share $6.81 Unrealized @ Report Date —
— SEQUENOM INC 1.1%
Value $14.13M Shares 10,023,842 Share Price $1.41 Est. Cost/Share $3.91 Unrealized @ Report Date —
— MOMENTA PHARMACEUTICALS INC 1.1%
Value $13.57M Shares 1,468,776 Share Price $9.24 Est. Cost/Share $14.44 Unrealized @ Report Date —
ACAD ACADIA PHARMACEUTICALS INC 1.1%
Value $13.56M Shares 485,100 Share Price $27.96 * Est. Cost/Share $21.84 Unrealized @ Report Date 0.0%
— RIGEL PHARMACEUTICALS INC 0.8%
Value $10.88M Shares 5,230,919 Share Price $2.08 Est. Cost/Share $3.43 Unrealized @ Report Date —
— HEARTWARE INTL INC 0.6%
Value $7.914M Shares 251,868 Share Price $31.42 Est. Cost/Share $86.47 Unrealized @ Report Date —
— ALIMERA SCIENCES INC 0.4%
Value $5.274M Shares 3,013,793 Share Price $1.75 Est. Cost/Share $4.88 Unrealized @ Report Date —
— AIMMUNE THERAPEUTICS INC 0.3%
Value $4.415M Shares 325,599 Share Price $13.56 Est. Cost/Share $25.32 Unrealized @ Report Date —
— ACELRX PHARMACEUTICALS INC 0.3%
Value $4.39M Shares 1,425,439 Share Price $3.08 Est. Cost/Share $5.78 Unrealized @ Report Date —
— SUNESIS PHARMACEUTICALS INC 0.3%
Value $3.766M Shares 6,974,854 Share Price $0.54 Est. Cost/Share $1.05 Unrealized @ Report Date —
EXAS EXACT SCIENCES CORP 0.2%
Value $2.671M Shares 396,276 Share Price $6.74 * Est. Cost/Share $12.83 Unrealized @ Report Date -50.1%
— IDERA PHARMACEUTICALS INC 0.2%
Value $2.49M Shares 1,257,748 Share Price $1.98 Est. Cost/Share $3.70 Unrealized @ Report Date —
ALGN ALIGN TECHNOLOGY INC 0.2%
Value $2.018M Shares 27,757 Share Price $72.70 * Est. Cost/Share $53.35 Unrealized @ Report Date +22.7%
— INTREXON CORP 0.1%
Value $1.596M Shares 47,100 Share Price $33.89 Est. Cost/Share $28.82 Unrealized @ Report Date —
— DICERNA PHARMACEUTICALS INC 0.1%
Value $1.436M Shares 267,890 Share Price $5.36 Est. Cost/Share $9.72 Unrealized @ Report Date —
— HISTOGENICS CORP 0.1%
Value $1.041M Shares 454,545 Share Price $2.29 Est. Cost/Share $11.00 Unrealized @ Report Date —
— ALCOBRA LTD 0.1%
Value $963K Shares 254,188 Share Price $3.79 Est. Cost/Share $6.09 Unrealized @ Report Date —
— OREXIGEN THERAPEUTICS INC 0.1%
Value $941K Shares 1,673,024 Share Price $0.56 Est. Cost/Share $6.46 Unrealized @ Report Date —
CYTK CYTOKINETICS INC 0.1%
Value $872K Shares 123,686 Share Price $7.05 * Est. Cost/Share $6.71 Unrealized @ Report Date +8.8%
— SOPHIRIS BIO INC 0.1%
Value $711K Shares 494,000 Share Price $1.44 Est. Cost/Share $2.60 Unrealized @ Report Date —
— MARINUS PHARMACEUTICALS INC 0.0%
Value $318K Shares 59,017 Share Price $5.39 Est. Cost/Share $8.34 Unrealized @ Report Date —
— ZOGENIX INC 0.0%
Value $264K Shares 28,600 Share Price $9.23 Est. Cost/Share $13.52 Unrealized @ Report Date —
QURE UNIQURE NV 0.0%
Value $243K Shares 20,453 Share Price $11.88 * Est. Cost/Share $26.34 Unrealized @ Report Date -43.9%